Skip to main content
Vetoquinol SA logo

Vetoquinol SA — Investor Relations & Filings

Ticker · VETO ISIN · FR0004186856 LEI · 969500YP0AETQIK48R39 PA Manufacturing
Open in API
Filings indexed 299 across all filing types
Latest filing 2025-04-25 Earnings Release
Country FR France
Listing PA VETO

About Vetoquinol SA

https://www.vetoquinol.com/en

Vetoquinol SA is a global animal health company that researches, develops, produces, and markets veterinary medicines and non-medicinal products. The company provides solutions for both companion animals (cats and dogs) and livestock (cattle and pigs). Its product portfolio addresses a wide range of therapeutic areas, including mobility, dermatology, anti-parasitics, antibiotics, internal medicine, and behavior management. Founded in 1933, the independent, family-owned business focuses on innovation and maintaining a close relationship with veterinary professionals to support animal well-being.

Recent filings

Filing Released Lang Actions
Quarterly financial reporting / First quarter financial report
Earnings Release Classification · 100% confidence The document explicitly states "SALES FOR 1ST QUARTER 2025" and provides detailed financial figures (€131 million total sales, breakdown by region and product type) for the first quarter. It also notes that the sales data is "unaudited data" and mentions the next publication is the AGM. This content is characteristic of an initial announcement of periodic financial results, focusing on key performance indicators for the quarter, rather than the comprehensive annual report (10-K) or a full interim report (IR) which typically includes full financial statements and management discussion and analysis (MDA). Since it is the initial release of quarterly results, the most appropriate classification is Earnings Release (ER). Q1 2025
2025-04-25 English
Information et rapport sur gouvernement d'entreprise
Annual Report Classification · 100% confidence The document is a 'Document d'enregistrement universel' (Universal Registration Document) for the fiscal year 2024, which explicitly includes the 'Rapport financier annuel' (Annual Financial Report). In the context of French corporate filings, this document serves as the equivalent of an Annual Report (10-K), containing comprehensive financial statements, management reports, governance details, and audit reports. It is not a mere announcement, as it contains the full substantive content of the annual reporting package. FY 2024
2025-04-25 French
DEPOT DEU VETOQUINOL
Annual Report (ESEF) Classification · 100% confidence FY 2024
2025-04-24 French
Inside Information / News release on accounts, results
Earnings Release Classification · 100% confidence The document is explicitly titled "ANNUAL RESULTS 2024" and contains comprehensive financial data for the fiscal year ended December 31, 2024, including detailed breakdowns of sales, EBITDA, EBIT, net income, and balance sheet components. It mentions the Board of Directors reviewed and approved the financial statements. This content structure is characteristic of a full annual financial report. Although it is not explicitly labeled as a '10-K' (the SEC filing equivalent), in the context of general corporate filings, a document presenting full-year audited/approved results is best classified as an Annual Report (AR) or, given the comprehensive nature, the closest equivalent to a 10-K if it were a US filer. Since the definitions provided list 'Annual Report (Code: 10-K)' for official yearly reports covering full financial performance, and this document clearly serves that function, 10-K is the most appropriate classification for a comprehensive annual financial disclosure, even if the company is French (Vetoquinol SA). The document is substantial (over 12,000 characters) and contains the results themselves, not just an announcement of them (ruling out RPA/RNS based on the 'Menu vs Meal' rule). FY 2024
2025-03-20 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 100% confidence The document is titled "RÉSULTATS ANNUELS 2024" (Annual Results 2024) and contains detailed financial figures for the full fiscal year, including Revenue (Chiffre d'affaires), Net Income (Résultat net), EBITDA, and a full comparative income statement (Compte de résultat simplifié) in tables. It explicitly mentions that the Board of Directors reviewed and approved the 2024 accounts on March 18, 2025. The content is a comprehensive summary of annual performance, not just a brief announcement of publication. Although it mentions the audit procedures are being finalized, the core content is the full annual financial disclosure. This strongly indicates an Annual Report or a document closely associated with it, like an Earnings Release (ER) or Management Discussion & Analysis (MDA). Given the depth of the financial tables and the focus on the full year's performance, it aligns best with the comprehensive nature of an Annual Report (10-K equivalent in structure, though likely filed as a French annual report document). Since the definitions provided do not have a specific code for a French 'Rapport Annuel' that isn't the US 10-K, and this document contains the full annual results summary, it is classified as the closest equivalent to a comprehensive annual filing, which is '10-K' for official yearly reports, or potentially 'ER' if it were only the highlights. However, the detail suggests more than just an ER. Since it is a full annual result disclosure, '10-K' is the most appropriate category for a comprehensive annual performance review, even if the source document is French and not the specific SEC form 10-K. FY 2024
2025-03-20 French
FORMULAIRE DE DECLARATION D'ACTIONS ET DE DROITS DE VOTE
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "FORMULAIRE DE DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration Form for Shares and Voting Rights) and explicitly references French commercial code articles (L. 233-8 II du code de commerce) and AMF (Autorité des marchés financiers) regulations. It details the total number of shares and voting rights as of a specific date, comparing them to a previous declaration date (February 5, 2025). This structure perfectly matches the requirements for reporting changes in total voting rights, which falls under the category of official results from shareholder votes or related regulatory disclosures concerning share capital structure changes. Given the options, this is a specific regulatory filing concerning voting rights and share capital structure. While it relates to share capital, the focus on voting rights declaration makes it distinct from a general 'Share Issue/Capital Change' (SHA). It is a mandatory periodic disclosure of voting rights. In the context of the provided definitions, this type of mandatory disclosure regarding voting rights and share capital structure changes, often filed monthly or upon significant change, is best classified as a specific regulatory filing. Since there isn't a dedicated 'Voting Rights Disclosure' code, and it deals with the structure of ownership/voting rights, it is closest to a mandatory regulatory filing. However, the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is 'Official results from shareholder votes at any general meeting (AGM or EGM)'. This document is a periodic declaration of total voting rights, not the *results* of a specific vote. Given the nature of mandatory periodic reporting on share capital and voting rights, and the lack of a better fit, it is a specific regulatory filing. If we strictly interpret the definitions, this is a mandatory disclosure related to share capital and voting rights, which is a core component of corporate governance reporting. Since it is a formal declaration to the regulator (AMF) about the capital structure and voting rights, it is a specific regulatory filing. Comparing it to the options: It is not an AGM result (DVA), not a general capital change (SHA), and not a director's dealing (DIRS). It is a mandatory regulatory filing concerning share capital structure. The closest fit among the specific codes that deal with ownership structure changes is 'Major Shareholding Notification' (MRQ), but this form is for the company reporting its *total* rights, not an individual crossing a threshold. Therefore, it defaults to a specific regulatory filing type. Given the French context and the nature of the document (L. 233-8 II declaration), it is a mandatory disclosure. Since it is a formal, structured report to the regulator, and doesn't fit the other specific categories well (especially since it's not a result of a vote, DVA), 'Regulatory Filings' (RNS) is the most appropriate fallback for a specific, non-standardized regulatory report not covered elsewhere. However, if we consider the content relates directly to voting rights, and DVA is the closest concept, we must re-evaluate. Since this is a periodic declaration of the *total* voting rights, not the *results* of a vote, DVA is a poor fit. RNS is the best fallback for specific regulatory reports not listed. I will assign RNS as the most appropriate general regulatory filing code.
2025-03-04 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.